HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis.

AbstractAIM:
To evaluate the efficacy of high-dose proton pump inhibitors (PPIs) vs low-dose PPIs for patients with upper gastrointestinal bleeding.
METHODS:
PubMed, Embase, the Cochrane Library, and Web of Science were searched to identify relevant randomized controlled trials (RCTs). Eligible trials were RCTs that compared high-dose PPI with low-dose PPI following endoscopic hemostasis. The primary endpoint was rebleeding; secondary endpoints were patient numbers that needed surgery, and mortality. The meta-analysis was performed with a fixed effects model or random effects model.
RESULTS:
Nine eligible RCTs including 1342 patients were retrieved. The results showed that high-dose intravenous PPI was not superior to low-dose intravenous PPI in reducing rebleeding [odds ratio (OR) = 1.091, 95% confidential interval (CI): 0.777-1.532], need for surgery (OR = 1.522, 95% CI: 0.643-3.605) and mortality (OR = 1.022, 95% CI: 0.476-2.196). Subgroup analysis according to different region revealed no difference in rebleeding rate between Asian patients (OR = 0.831, 95% CI, 0.467-1.480) and European patients (OR = 1.263, 95% CI: 0.827-1.929).
CONCLUSION:
Low-dose intravenous PPI can achieve the same efficacy as high-dose PPI following endoscopic hemostasis.
AuthorsLiu-Cheng Wu, Yun-Fei Cao, Jia-Hao Huang, Cun Liao, Feng Gao
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 16 Issue 20 Pg. 2558-65 (May 28 2010) ISSN: 2219-2840 [Electronic] United States
PMID20503458 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
Chemical References
  • Proton Pump Inhibitors
Topics
  • Databases, Factual
  • Dose-Response Relationship, Drug
  • Gastrointestinal Hemorrhage (drug therapy, mortality, prevention & control, surgery)
  • Hemostasis, Endoscopic
  • Humans
  • Proton Pump Inhibitors (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Upper Gastrointestinal Tract (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: